XML 24 R7.htm IDEA: XBRL DOCUMENT v3.25.3
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Total Varex Equity
Total Varex Equity
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Noncontrolling Interests
Common stock, shares, outstanding, beginning balance (in shares) at Sep. 30, 2022         40,100,000            
Stockholders' equity, outstanding, beginning balance at Sep. 30, 2022 $ 542.6 $ (28.5) $ 529.3 $ (28.5) $ 0.4 $ 469.1 $ (34.6) $ 0.1 $ 59.7 $ 6.1 $ 13.3
Increase (Decrease) in Stockholders' Equity                      
Net income 47.9   47.4           47.4   0.5
Exercise of stock options 0.2   0.2     0.2          
Common stock issued upon vesting of restricted shares (in shares)         200,000            
Shares withheld on vesting of restricted stock (in shares)         (100,000)            
Shares withheld on vesting of restricted stock (1.4)   (1.4)     (1.4)          
Common stock issued under employee stock purchase plan (in shares)         300,000            
Common stock issued under employee stock purchase plan 3.9   3.9     3.9          
Share-based compensation 13.5   13.5     13.5          
Gain on forward contracts 0.1   0.1         0.1      
Unrealized (loss) gain on available-for-sale securities 0.1   0.1         0.1      
Unrealized loss on defined benefit obligations (1.0)   (1.0)         (1.0)      
Foreign currency translation adjustments (0.5)   (0.5)         (0.5)      
Other (0.8)   (0.3)     (0.3)         (0.5)
Common stock, shares, outstanding, ending balance (in shares) at Sep. 29, 2023         40,500,000            
Stockholders' equity, outstanding, ending balance at Sep. 29, 2023 576.1   562.8   $ 0.4 450.4   (1.2) 113.2   13.3
Increase (Decrease) in Stockholders' Equity                      
Net income (48.3)   (48.8)           (48.8)   0.5
Common stock issued upon vesting of restricted shares (in shares)         400,000            
Shares withheld on vesting of restricted stock (in shares)         (100,000)            
Shares withheld on vesting of restricted stock (2.2)   (2.2)     (2.2)          
Common stock issued under employee stock purchase plan (in shares)         300,000            
Common stock issued under employee stock purchase plan 3.8   3.8     3.8          
Share-based compensation 15.2   15.2     15.2          
Gain on forward contracts 0.1   0.1         0.1      
Unrealized (loss) gain on available-for-sale securities 0.1   0.1         0.1      
Unrealized loss on defined benefit obligations 0.0                    
Foreign currency translation adjustments (1.9)   (1.9)         (1.9)      
Business acquisitions 0.7                   0.7
Other $ (0.4)                   (0.4)
Common stock, shares, outstanding, ending balance (in shares) at Sep. 27, 2024 41,094,179       41,100,000            
Stockholders' equity, outstanding, ending balance at Sep. 27, 2024 $ 543.2   529.1   $ 0.4 467.2   (2.9) 64.4   14.1
Increase (Decrease) in Stockholders' Equity                      
Net income (69.9)   (70.3)           (70.3)   0.4
Common stock issued upon vesting of restricted shares (in shares)         400,000            
Shares withheld on vesting of restricted stock (in shares)         (100,000)            
Shares withheld on vesting of restricted stock (1.9)   (1.9)     (1.9)          
Common stock issued under employee stock purchase plan (in shares)         300,000            
Common stock issued under employee stock purchase plan 3.3   3.3     3.3          
Share-based compensation 14.8   14.8     14.8          
Gain on forward contracts 0.1   0.1         0.1      
Unrealized (loss) gain on available-for-sale securities (0.1)   (0.1)         (0.1)      
Unrealized loss on defined benefit obligations 0.0                    
Foreign currency translation adjustments (2.3)   (2.3)         (2.3)      
Other $ (0.6)   (0.1)     (0.1)         (0.5)
Common stock, shares, outstanding, ending balance (in shares) at Oct. 03, 2025 41,689,672       41,700,000            
Stockholders' equity, outstanding, ending balance at Oct. 03, 2025 $ 486.6   $ 472.6   $ 0.4 $ 483.3   $ (5.2) $ (5.9)   $ 14.0